1-Hydroxy-2-methyl-2-buten-4-yl 4-diphosphate (HDMAPP)

Catalog No.:  I-M055
MW: 313.18
CAS: 396726-03-7

Description:  Isoprenoid compounds are a diverse group of natural products which are essential components in all cells. Isoprenoids are biosynthesized from the simple precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). Eukaryotes, fungi, and some gram-positive bacteria produce IPP through the mevalonate (MVA) pathway whereas gram-negative and some gram-positive bacteria utilize the non-mevalonate or 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway. 1-Hydroxy-2-methyl-2-buten-4-yl 4-diphosphate (HDMAPP or HMBPP) is an intermediate in the non-mevalonate pathway and is biosynthesized from 2-C-Methyl-D-erythritol 2,4-cyclophosphate (cMEPP) by IspG (GcpE). It is the substrate for IspH (LytB) yielding IPP and DMAPP. In addition, HDMAPP is the most potent VγVδ T-cell activator identified.

Provided as the tris-ammonium salt


-20°C or below.

Featured in Publications

1) deBarros, A., M. Chaves-Ferreira, et al. (2011). "CD70–CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes." European Journal of Immunology 41(1): 195.
2) Spencer, C. T., G. Abate, et al. (2008). "Only a Subset of Phosphoantigen-Responsive γ9δ2 T Cells Mediate Protective Tuberculosis Immunity." The Journal of Immunology 181(7): 4471-4484.
3) Moens, E., M. Brouwer, et al. (2011). "IL-23R and TCR signaling drives the generation of neonatal Vγ9Vδ2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17." J Leukoc Biol 89(5): 743-52.

Bulk discounts available, please email for information.

Options/Sizes Pricing
I-M055-1mg $ 126.00
I-M055-10mg $ 926.00
Additional Information:
Tech Data Sheet - TDS_I-M055_Rev 4

Add a specific quantity to your cart    *  

Back to the webstore startpage      Back to the product overview      Your Shopping Cart      Terms of Service

assay and reagents for drug discovery in lipid signaling pathways